4:49 pm Acceleron Pharma and Celgene (CELG) announce interim clinical data for sotatercept demonstrating dose dependent increases in hemoglobin in patients with end stage renal disease on hemodialysis
View todays social media effects on XLRN
View the latest stocks trending across Twitter. Click to view dashboard
See who Acceleron is hiring next, click here to view
